在糖尿病创面再上皮化障碍中Glucose/AMPK/CFTR轴对上皮间质可塑性的动态调节机制
批准号:
82060155
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
董俭达
依托单位:
学科分类:
糖尿病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
董俭达
中文摘要
再上皮化障碍(RED)是糖尿病皮肤创面延迟愈合(DWH)的关键事件,与DWH恶化及慢性难愈性创面发生密切相关,目前RED调控机制还未阐明,制约临床治疗发展。因此寻找RED相关的新分子靶标重要而急切。我们前期研究发现创面再上皮化(RE)角质细胞(KCs)先发生上皮间质转化(EMT),后期发生间质上皮转化(MET),具有上皮间质可塑性(EMP)特征;伴随EMP改变,腺苷酸活化蛋白激酶(AMPK)和囊性纤维化跨膜转导调节因子(CFTR)出现先下调后上调的有秩序变化;高浓度葡萄糖(glucose)诱导KCs细胞发生MET并AMPK及CFTR蛋白上调表达。本项目以Glucose/AMPK/CFTR间相互作用作为切入点,建立高糖处理KCs细胞体外培养模型及糖尿病大鼠DWH模型,模拟RED过程,应用AMPK激活剂干预,研究KCs细胞EMP相关变化规律,为糖尿病RED调控的分子机理研究提供新证据。
英文摘要
Re-epithelialization disorder (RED) is a key event of delayed wound healing (DWH) in diabetes mellitus. It is closely related to the deterioration of DWH and the occurrence of chronic refractory wound. At present, the regulatory mechanism of RED has not been clarified, which restricts the development of clinical treatment. Therefore, it is important and urgent to find new molecular targets related to RED. In our previous study, we found that the RE keratinocytes (KCs) first undergo epithelial-mesenchymal transformation (EMT) during wound healing, and later undergo mesenchymal-epithelial transformation (MET), which is characterized by epithelial plasticity (EMP). At the same time, AMP activated protein kinase (AMPK) and cystic fibrosis transmembrane conductance regulator(CFTR) are down regulated and up regulated in an orderly manner.High level glucose induced the EMT and upregulated the expression of AMPK and CFTR of KCs cell. In this project, the interaction between glucose / AMPK / CFTR was used as the starting point to establish KCs cell culture model in vitro and DWH model in diabetic rats, to simulate the process of RED, and to study the dynamic changes of EMP status of KCs cells by the intervention of AMPK activator, so as to provide new experimental evidence for the study of molecular regulatory mechanism of diabetic RED issues.
中国是糖尿病患者数量最多的国家,糖尿病患者易发生皮肤创面延迟愈合(DWH)问题,再上皮化障碍(RED)是糖尿病DWH的关键事件,与DWH恶化及慢性难愈性创面形成密切相关,目前RED调控机制还未阐明,制约临床治疗发展,急需探索和发现影响RED过程的新分子靶标及作用机理。本研究首次鉴定了囊性纤维化跨膜转导调节因子(CFTR)对角质形成细胞(KCs)分化和移行的主动调控作用;我们发现创面再上皮化(RE)区KCs细胞先发生上皮间质转化(EMT),后期发生间质上皮转化(MET),具有上皮间质可塑性(EMP)特征;伴随EMP改变,腺苷酸活化蛋白激酶(AMPK)和囊性纤维化跨膜转导调节因子(CFTR)出现先下调后上调的有秩序变化;高浓度葡萄糖(glucose)诱导 KCs 细胞发生MET并AMPK及CFTR 蛋白上调表达;糖尿病大鼠出现DWH问题,并伴RED,创面RE区AMPK异常高表达;AMPK激活剂二甲双胍创面局部处理可减轻糖尿病大鼠DWH问题,改善RED,RE区AMPK下调表达。我们首次提出Glucose/AMPK/CFTR 轴的概念,发现糖尿病创面高糖微环境,导致KCs细胞CFTR和AMPK表达上调,导致EMP状态异常,KCs细胞增殖能力和移行能力下降,RED发生,引发DWH;如果主动针对CFTR和AMPK干预,可能是治疗DWH的潜在方法,提示Glucose/AMPK/CFTR 轴通过EMP途径动态调节创面愈合 RE过程的新机制,为糖尿病 DWH 的机制研究提供新的实验线索和证据。
国内基金
海外基金